# Salidroside Selectively Binds to SEC23A and Ameliorates Psychological Stress-Induced Hyperpigmentation

**Authors:** Man Yang, Xiaoyu Sun, Da Wang, Huizhong Nie, Kang Cheng, Jie Gu, Lu Chen, Yuxuan Zhang, Lingli Yang, Ichiro Katayama, Yiming Li, Huali Wu

PMC · DOI: 10.3390/ph19030487 · Pharmaceuticals · 2026-03-16

## TL;DR

Salidroside reduces stress-induced skin darkening by targeting SEC23A and modulating specific signaling pathways.

## Contribution

Salidroside selectively binds to SEC23A to inhibit stress-induced melanogenesis via dual ERK and p38 MAPK signaling.

## Key findings

- Salidroside reduced melanin content and melanogenic protein expression in stress-stimulated melanocytes.
- Salidroside reversed stress-induced hyperpigmentation in human skin, zebrafish, and mice.
- SEC23A knockdown enhanced Salidroside's anti-melanogenic effects in stress models.

## Abstract

Background/Objectives: Psychological stress triggers excessive melanin deposition via neuroendocrine pathways, yet targeted interventions for stress-induced hyperpigmentation remain limited. Salidroside (SAL) exhibits established depigmenting effects in UV-induced models and possesses neuroprotective properties. This study investigated SAL’s efficacy in psychological stress-induced hyperpigmentation and elucidated its underlying mechanisms. Methods: B16F10 melanocytes, C57BL/6J mice, zebrafish, and human foreskin organ cultures were subjected to stress factor (Substance P/cortisol) or α-MSH/IBMX stimulation to model psychological stress-induced and canonical cAMP-driven hyperpigmentation, respectively. Melanin content, tyrosinase activity, melanosome maturation (transmission electron microscopy/HMB45 staining), and melanogenic protein/mRNA expression were assessed. Drug Affinity Responsive Target Stability (DARTS) assays, molecular docking, and SEC23A siRNA knockdown were employed to identify and validate SAL’s molecular target and downstream signaling pathways. Results: SAL dose-dependently reduced melanin content, tyrosinase activity, and TYR/TRP-1/DCT expression in SP/Cort-stimulated melanocytes, exhibiting greater potency (200 μM) than in IBMX-induced models (400 μM). SAL reversed SP/Cort-induced hyperpigmentation in human skin explants, zebrafish, and C57BL/6J mice, and normalized melanosome number/maturation. DARTS and molecular docking identified SEC23A as a direct SAL-binding target. SP/Cort specifically upregulated SEC23A, which SAL suppressed. SAL concurrently activated the SEC23A-p-ERK-MITF axis and inhibited the NK1R-p38-MITF axis in the stress model. SEC23A knockdown potentiated SAL’s anti-melanogenic effects specifically in SP/Cort-stimulated cells. Conversely, in IBMX-induced models, SEC23A remained unchanged, and SAL acted via PKA/CREB, PI3K/AKT, and Wnt/β-catenin pathways. Conclusions: SEC23A is a novel core target in psychological stress-induced hyperpigmentation. SAL selectively binds SEC23A to inhibit stress-induced melanogenesis via dual ERK and p38 MAPK signaling axes, demonstrating etiological specificity distinct from canonical cAMP pathway inhibition.

## Linked entities

- **Genes:** SEC23A (SEC23 homolog A, COPII component) [NCBI Gene 10484], TYR (tyrosinase) [NCBI Gene 7299], PRSS1 (serine protease 1) [NCBI Gene 5644], DCT (dopachrome tautomerase) [NCBI Gene 1638], EPHB2 (EPH receptor B2) [NCBI Gene 2048], MITF (melanocyte inducing transcription factor) [NCBI Gene 4286], TACR1 (tachykinin receptor 1) [NCBI Gene 6869], CRK (CRK proto-oncogene, adaptor protein) [NCBI Gene 1398], PKA (cAMP dependent protein kinase) [NCBI Gene 7451422], CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], Wnt (protein Wnt-2) [NCBI Gene 100641115], ctnnb1.S (catenin beta 1 S homeolog) [NCBI Gene 380441]
- **Chemicals:** Salidroside (PubChem CID 159278), Substance P (PubChem CID 36511), cortisol (PubChem CID 5754), IBMX (PubChem CID 3758)
- **Species:** Danio rerio (taxon 7955), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, TYR (tyrosinase) [NCBI Gene 7299] {aka ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3}, TYRP1 (tyrosinase related protein 1) [NCBI Gene 7306] {aka CAS2, CATB, GP75, OCA3, TRP, TRP1}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, CORT (cortistatin) [NCBI Gene 1325] {aka CST-14, CST-17, CST-29, SST2}, MITF (melanocyte inducing transcription factor) [NCBI Gene 4286] {aka CMM8, COMMAD, MI, MITF-A, WS2, WS2A}, SEC23A (SEC23 homolog A, COPII component) [NCBI Gene 10484] {aka CLSD, hSec23A}, DCT (dopachrome tautomerase) [NCBI Gene 1638] {aka OCA8, TRP-2, TYRP2}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, TACR1 (tachykinin receptor 1) [NCBI Gene 6869] {aka NK1R, NKIR, SPR, TAC1R}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}
- **Diseases:** Hyperpigmentation (MESH:D017495)
- **Chemicals:** SAL (MESH:C009172), cAMP (-), cortisol (MESH:D006854), SP (MESH:C000604007), IBMX (MESH:D015056), melanin (MESH:D008543)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13029700/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13029700/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC13029700/full.md

---
Source: https://tomesphere.com/paper/PMC13029700